Return to home page
Searching: Muskingum library catalog
We are currently experiencing delivery delays for items requested from other institutions while transitioning to a new statewide delivery service. Please contact your library with questions or advice about alternative resources. Thank you for your patience!
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
EBOOK
Author Bain, Lisa J.,
Title Advancing therapeutic development for pain and opioid use disorders through public-private partnerships : proceedings of a workshop / Lisa Bain, Sheena M. Posey Norris, and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.
Imprint Washington, DC : The National Academies Press, [2018]
2018

Author Bain, Lisa J.,
Subject Chronic pain -- Treatment -- United States -- Congresses.
Opioid abuse -- Treatment -- United States -- Congresses.
Opioid-Related Disorders -- therapy.
Chronic Pain -- therapy.
United States.
Alt Name Norris, Sheena M. Posey,
Stroud, Clare,
National Academies of Sciences, Engineering, and Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders,
Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships (Workshop) (2017 : Washington, D.C.), author.
Description 1 online resource (x, 94 pages) : color illustrations
Bibliography Note Includes bibliographical references (pages 69-76).
Contents Introduction and background -- Exploring challenges to developing treatments for pain and opioid use disorders -- Exploring the state of the science and preclinical models for pain therapeutic development -- Clinical development of non-addictive pain medications -- Therapeutic development for opioid disorders and overdose prevention and reversal -- Public-private partnerships to advance pain and opioid use disorders research and development -- Appendixes.
Summary "Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. Estimates show that more than 11 percent of the American population suffer from chronic pain, yet the federal pain research investment has been minimal. In parallel with a gradual increased recognition of the problems of treating chronic pain, the opioid epidemic has emerged as a growing public health emergency. The intersection of these two crises lies in the fact that an unintended consequence of treating pain has been an increasing number of opioid prescriptions and diversion of drugs for illicit purposes. In May 2017, the National Institutes of Health (NIH), and the National Institute on Drug Abuse announced a public-private partnership to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To advance the planning of NIH's anticipated public-private partnerships, the National Academies' Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together a diverse group of stakeholders from academia, federal agencies, advocacy organizations and companies developing therapeutics for pain and opioid use disorders. Participants discussed potential strategies to accelerate development of non-addictive pain medications and treatments for opioid use disorders. This publication summarizes the presentations and discussions from the workshop"--Publisher's description.
Note Online resource; title from PDF title page (National Academies Press, viewed June 4, 2018).
ISBN 9780309474023 (electronic bk.)
0309474027 (electronic bk.)
9780309473996 (paperback)
0309473993 (paperback)
9780309474009
0309474000
ISBN/ISSN 10.17226/25060
OCLC # 1039687594
Additional Format Print version: Bain, Lisa J. Advancing therapeutic development for pain and opioid use disorders through public-private partnerships. Washington, DC : the National Academies Press, [2018] 9780309473996 (OCoLC)1042073835



If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team